# EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances

Page: https://stenobird.com/podcast/lung-cancer-update-827388/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances
Text version: https://stenobird.com/podcast/lung-cancer-update-827388/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md
Podcast: [Lung Cancer Update](https://stenobird.com/podcast/lung-cancer-update-827388)
Published: 2026-04-27T19:40:00+00:00
Episode link: https://lung-cancer-update.captivate.fm/episode/6011-yir2025-egfrnsclc
Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/ee596c70-4da8-401a-a91a-1209dd1b9a77.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances
Duration seconds: 3446

## Resource

Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported over the past year. CME information and select publications here .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/lung-cancer-update-827388/egfr-mutant-non-small-cell-lung-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.